| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 22, 2015 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,266 | -- | 26,938 | |
| Jul 22, 2015 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,022 | -- | 6,022 | |
| Jul 22, 2015 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,266 | -- | 53,525 | |
| Jul 22, 2015 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,022 | -- | 6,022 | |
| Jul 22, 2015 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,287 | -- | 32,988 | |
| Jul 22, 2015 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 14,704 | -- | 14,704 | |
| Jul 22, 2015 | SVP, GM - Oncology | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,716 | -- | 5,716 | |
| Jul 22, 2015 | EVP and CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,428 | -- | 24,326 | |
| Jul 22, 2015 | EVP and CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 18,617 | -- | 18,617 | |
| Jul 22, 2015 | EVP and CCO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,237 | -- | 7,237 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.